Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Constitutional thrombocytopathy with subnormal response to thromboxane A2

M Samama, C Lecrubier, J Conard

    British Journal of Haematology
    |June 1, 1981
    PubMed
    Summary

    A novel congenital platelet disorder was identified in a woman with a lifelong bleeding issue. This condition involves abnormal platelet release and aggregation, linked to reduced sensitivity to prostaglandin endoperoxides and thromboxane A2.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological Reaction.

    Platelets·2010
    Same author

    Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy.

    Clinical pharmacology and therapeutics·2008
    Same author

    [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].

    Gynecologie, obstetrique & fertilite·2008
    Same author

    Atypical mutations of the prothrombin gene at positions 20,209 and 20,218, and a novel mutation at position 20,219. Report on 10 patients.

    Journal of thrombosis and haemostasis : JTH·2007
    Same author

    Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.

    Journal of thrombosis and haemostasis : JTH·2006
    Same author

    Fibrinogen Paris IX: a case of symptomatic hypofibrinogenemia with Bbeta Y236C and Bbeta IVS7-1G-->C mutations.

    Journal of thrombosis and haemostasis : JTH·2006

    Area of Science:

    • Hematology
    • Molecular Biology
    • Genetics

    Background:

    • Congenital platelet dysfunction presents as a lifelong bleeding disorder.
    • Exclusion of known thrombopathias and von Willebrand's disease is crucial for diagnosis.

    Observation:

    • A young woman presented with a severe lifelong bleeding disorder.
    • Platelets were morphologically normal with normal shape change, contraction, and thromboxane A2 synthesis.

    Findings:

    • Abnormal platelet release reaction observed.
    • Depressed platelet aggregation response to various agonists, including ADP, adrenalin, collagen, thrombin, sodium arachidonate, and vasopressin.
    • Decreased platelet sensitivity to prostaglandin endoperoxides and thromboxane A2 identified as the cause, with increased platelet cAMP content.

    Related Experiment Videos

    Implications:

    • This finding suggests a new category of congenital platelet dysfunction.
    • Understanding this defect can lead to improved diagnosis and management of bleeding disorders.
    • Further research into the molecular mechanisms underlying this platelet defect is warranted.